Skip to main content
Diaeta
Illustration of sugar cubes, a stevia sprig, a glass of water and sweetener molecules on a turquoise and green background
General Nutrition

Sweeteners: The Complete Scientific Guide 2026

Aspartame, sucralose, stevia, erythritol, polyols: what the studies really say in 2026. EFSA re-evaluations, the WHO guideline, effects on weight, blood sugar, the heart, the microbiota and digestion, pregnancy, children and practical cooking tips. An evidence-based guide to help you make informed choices, without hunger and with pleasure.

Pierre Abou-Zeid

Pierre Abou-Zeid

INAMI Registered Dietitian

October 6, 2026
19 min

Aspartame, sucralose, stevia, erythritol: researchers have never studied sweeteners so closely, and people have never argued about them so much. In 2023, the WHO advised against using them for weight control, and the International Agency for Research on Cancer classified aspartame as "possibly carcinogenic". Between 2024 and 2026, the European Food Safety Authority (EFSA) re-evaluated almost every authorised sweetener. At the same time, large European trials showed that sweeteners help people maintain weight loss.

With such mixed messages, you may wonder whether to keep your diet soda, switch to water or go back to sugar. This guide gathers the data published up to October 2026, checked against primary sources: official opinions, randomised trials, large cohorts and meta-analyses.

Our promise at Diaeta: evidence-based nutrition support, without hunger and with foods you find tasty. Sweeteners can be part of that path, as long as you know which ones to choose, for whom and for what purpose.


1. The Key Facts in 10 Points

  1. Replacing sugar with a sweetener leads to an average loss of 0.7 to 1.6 kg over a few months to a year. Adding a sweetener without removing any sugar brings no benefit.
  2. Water remains the best drink. Compared with water, diet drinks show no clear difference in weight.
  3. Observational studies link sweeteners to more diabetes, cardiovascular disease and cancer. Much of this link comes from the fact that people already at risk choose diet products.
  4. The WHO guideline (2023) is a conditional recommendation on weight control. It excludes people with diabetes and does not question toxicological safety.
  5. EFSA confirmed the safety of aspartame and sucralose, and raised the acceptable daily intakes of saccharin, acesulfame K and neotame.
  6. Erythritol and xylitol, at high doses (30 g), increase blood platelet activity. Reasonable caution makes sense for people at high cardiovascular risk.
  7. Sucralose is not suitable for oven baking: above 120 °C, it can form chlorinated compounds.
  8. Polyols (sorbitol, mannitol, maltitol, xylitol) cause most digestive complaints and belong to the FODMAPs.
  9. During pregnancy and breastfeeding, the data remain observational. Water first, sweeteners in moderation.
  10. Reducing sweet taste does not change your liking for sweetness: a six-month trial showed this in 2025.

2. Three Families, Three Different Questions

The word "sweetener" covers three families of substances. They differ in chemistry, effects and regulatory status.

Family Examples Calories The question that matters
Intense sweeteners Aspartame (E951), sucralose (E955), acesulfame K (E950), saccharin (E954), cyclamate (E952), steviol glycosides (E960) Zero at the doses used What do long-term studies say?
Polyols (sugar alcohols, the "-ols") Sorbitol (E420), mannitol (E421), maltitol (E965), xylitol (E967), erythritol (E968), isomalt (E953) 2.4 kcal/g on the European label; 0 for erythritol How well does your gut tolerate them? What effect on platelets?
Rare sugars Allulose, tagatose Low Are they authorised in Europe?

2.1 Sweetening Power and Acceptable Daily Intake

The acceptable daily intake (ADI) is the amount a person can consume every day, over a lifetime, without appreciable health risk. It includes a safety margin, often a factor of 100 below the no-observed-effect dose in animals.

Sweetener Sweetening power (sugar = 1) European ADI Latest evaluation
Aspartameabout 20040 mg/kg/dayEFSA 2013, reconfirmed in 2026
Sucraloseabout 60015 mg/kg/dayEFSA, February 2026
Acesulfame Kabout 20015 mg/kg/day (previously 9)EFSA 2025
Saccharin200 to 7009 mg/kg/day (previously 3.8)EFSA 2024
Cyclamate30 to 807 mg/kg/dayRe-evaluation expected in 2027
Steviol glycosides200 to 4004 mg/kg/dayEFSA 2024 (increase refused)
Erythritol0.70.5 g/kg/dayEFSA 2023
Xylitol1Not specifiedPolyols under re-evaluation
Sorbitol, mannitol0.5 to 0.6Not specifiedPolyols under re-evaluation

To give you a benchmark: according to the WHO, a 70 kg adult would need to drink more than 9 to 14 cans of diet soda a day to exceed the aspartame ADI, with no other source. In Belgium, measured intakes stay well below the ADIs: at the 95th percentile, from 13 % (aspartame) to 31 % (acesulfame K) of the acceptable intake.


3. Safety: What EFSA Concluded in 2024-2026

The European Union required the re-evaluation of every additive authorised before 2009. Sweeteners came last. Here is what EFSA has published in recent years:

  • Saccharin (2024): ADI raised to 9 mg/kg/day. The bladder tumours seen in male rats, which had justified the old limit, are not relevant to humans.
  • Acesulfame K (2025): ADI raised to 15 mg/kg/day, with no genotoxicity concern for the molecule.
  • Neotame (2025): ADI raised from 2 to 10 mg/kg/day.
  • Sucralose (February 2026): ADI of 15 mg/kg/day maintained. EFSA found no genotoxicity concern, including for sucralose-6-acetate, an impurity that raised alarm in 2023. However, it could not reach a conclusion on its use in baking, because of the chlorinated compounds that can form during cooking.
  • Aspartame (September 2026): EFSA reconfirms the ADI of 40 mg/kg/day.
  • Erythritol (2023): ADI of 0.5 g/kg/day, set on the laxative effect. The highest consumers, children and teenagers, can exceed it.
  • Steviol glycosides (2024): EFSA declines to raise the ADI of 4 mg/kg/day.

3.1 What the Label Says

  • "With sweetener(s)" next to the product name, or "with sugar(s) and sweetener(s)".
  • "Contains a source of phenylalanine" for aspartame. This statement concerns people with phenylketonuria, a rare genetic disease.
  • "Excessive consumption may produce laxative effects" above 10 % added polyols.

Foods for infants and children aged 1 to 3 (infant formula, baby food jars, infant cereals) may not contain any sweetener.

3.2 The Newcomers

  • Allulose: not authorised in the European Union. In 2025, EFSA concluded that its safety "cannot be established" for lack of sufficient data. It is still sold online.
  • Monk fruit (luo han guo): since October 2024, water-based decoctions of the fruit count as a traditional food. Purified mogroside extracts are not authorised.
  • Brazzein (sweet protein): authorised in the United States in 2024, not in Europe.

4. The 2023 WHO Guideline: What It Actually Says

In May 2023, the WHO recommended against using sweeteners to control weight or reduce the risk of chronic disease. The media often summed up this text as "sweeteners are dangerous". Four details change how you should read it:

  1. The recommendation is conditional, based on low-certainty evidence.
  2. It excludes people who already have diabetes.
  3. It does not cover polyols or rare sugars.
  4. It is not a toxicological evaluation and changes no ADI.

Other institutions read the same data differently. The American Diabetes Association (2026) accepts sweeteners "in moderation and in the short term" to replace sugary products, and puts water first. British dietitians and diabetes specialists (2025) see them as a useful tool to cut sugar. The European recommendations for diabetes (EASD 2023) state that they can replace sugars in foods and drinks.

Key insight: All institutions agree on one point. Water comes first, and sweeteners serve as a transition tool to reduce sugar. They disagree on how long that use remains acceptable.


5. Why Studies Contradict Each Other

If you read the press, you will find opposite headlines from one week to the next. This confusion comes from two types of studies that answer different questions.

Randomised trials Cohort studies
Comparison Sweetener versus sugar or versus water Consumers versus non-consumers
Duration A few weeks to one year Several years
Result Small benefit on weight, neutral effect on blood sugar Risks increased by 10 to 70 % depending on the disease
Strength Establishes cause Follows large populations over a long time

Three biases explain the gap:

  • Reverse causation. People with overweight, prediabetes or cardiovascular risk switch to diet products. The disease then comes before the consumption, and the sweetener becomes a marker of risk.
  • Confounding. High consumption of diet products often goes with an eating pattern rich in ultra-processed foods.
  • The wrong comparator. Cohorts compare sweeteners with "nothing". The useful question is: sweetener instead of sugar?

An umbrella review published in 2025 illustrates this. Analysed crudely, cohorts link sweeteners to more obesity, diabetes and mortality. Analysed as "sweetener instead of sugary drinks", they link them to lower weight, less coronary heart disease and lower mortality.


6. Weight: The Randomised Trials

Study Participants Result
Rogers and Appleton, 2021 (meta-analysis) 88 studies Sweetener versus sugar: −1.06 kg. Versus water: no difference.
McGlynn, 2022 (meta-analysis) Adults with overweight, at risk of diabetes or with diabetes Diet drinks instead of sugary drinks: −1.06 kg, less body fat and less liver fat.
SWEET, 2025 (one-year European trial) Adults with overweight after weight loss 1.6 kg of additional weight loss maintained at one year with sweeteners.
DRINK, 2012 (18 months, double-blind) Children aged 4 to 11 A diet drink instead of a sugary drink: less weight gain and less body fat.

The benefit depends on how much sugar you remove. If you drink a litre of sugary soda a day, switching to the diet version makes a real difference to your intake. If you already drink water, adding diet products does nothing for your weight. To learn more about appetite regulation, read our article on the science of satiety.


7. Blood Sugar and Diabetes

A meta-analysis of 36 trials (2023) found no effect of sweetened drinks on blood sugar, insulin or gut hormones in the following two hours. The response resembles that of water.

An Israeli study published in Cell in 2022 added nuance to this picture. In 120 adults, two weeks of saccharin or sucralose changed glucose tolerance, with large differences from one person to the next, linked to the microbiota. However, the sachets contained glucose as a carrier, and the study lasted only two weeks. The one-year SWEET trial found no difference in insulin sensitivity.

In the French NutriNet-Santé cohort (105,588 adults followed for nine years), the highest sweetener consumers had a 69 % higher risk of type 2 diabetes. The threshold for "high consumption" was low, about half a can of diet soda a day, and the authors acknowledge that reverse causation cannot be ruled out.

In practice, if you have diabetes: sweeteners do not raise your blood sugar and let you cut carbohydrates. Water remains preferable. Watch out for "sugar-free" products that contain polyols, flours or fats: those count. Our complete guide to type 2 diabetes explains these choices in detail.


8. Heart and Blood Vessels: The Case of Erythritol and Xylitol

Large cohorts link diet drinks to a slightly higher cardiovascular risk. In NutriNet-Santé, the absolute difference remains small: 346 versus 314 cases per 100,000 people per year. Among people with diabetes in the UK Biobank, replacing a sugary drink with a diet drink did not change the risk of atrial fibrillation.

8.1 A More Precise Signal: Platelets

A Cleveland Clinic team published three studies between 2023 and 2024:

  • In cardiology patients, a high blood level of erythritol was associated with nearly twice as many heart attacks and strokes over three years.
  • In healthy volunteers, 30 g of erythritol raised its blood level more than 1,000-fold and increased platelet aggregation in every one of them. The same dose of glucose had no such effect.
  • Xylitol showed the same profile.

These results call for careful interpretation. Your body makes erythritol itself, and its blood level rises with hyperglycaemia and metabolic syndrome. No study links dietary erythritol intake to heart attacks, and no trial has measured this risk.

Our advice: if you have a history of thrombosis, heart attack or stroke, keep large doses of erythritol and xylitol modest ("keto" drinks, sugar-free pastries, powdered table sweetener by the spoonful). A xylitol chewing gum contains about 0.3 g: you would need nearly 90 to reach the 30 g studied.


9. Cancer: What Does the Aspartame Classification Mean?

In 2023, the International Agency for Research on Cancer placed aspartame in group 2B, "possibly carcinogenic to humans", on limited evidence of a link with liver cancer. This classification measures the strength of the evidence for a hazard, not the size of the risk at the doses people consume. The same year, the FAO/WHO expert committee concluded that the ADI of 40 mg/kg remained valid.

  • In NutriNet-Santé, the highest consumers had a 13 % higher cancer risk.
  • In the Women's Health Initiative (98,786 women followed for 21 years), diet drinks showed no link with liver cancer. Sugary drinks did.
  • A 2025 review even found an inverse association with colorectal cancer.

A 2025 study in mice showed that sucralose could reduce the effectiveness of cancer immunotherapy by altering the microbiota. In 157 patients, higher sucralose intake was associated with a weaker response. This work remains a hypothesis. If you are receiving immunotherapy, water remains the simplest choice.


10. Gut Microbiota

The effects of sweeteners on the microbiota depend on the molecule, the dose and the person:

  • Saccharin and sucralose account for most of the signals, in trials lasting two to ten weeks.
  • Pure saccharin, pure aspartame and sucralose, stevia: several trials show no change.
  • A 2026 meta-analysis on sucralose found no overall effect on microbiota diversity or on blood sugar.
  • The SWEET trial, the longest (one year), shows an increase in bacteria that produce short-chain fatty acids, a favourable profile.

To date, no study shows clinical harm linked to the microbiota. To understand the role of these bacteria, see our guide to the human microbiome.


11. Digestion, Polyols and Irritable Bowel Syndrome

Your gut absorbs polyols poorly. They draw water into the intestine and ferment in the colon: gas, bloating, loose stools. These effects depend on the dose and add up when you combine several polyols.

Polyol Tolerance Observed threshold
ErythritolThe best35 g in a drink with no notable symptoms
XylitolIntermediateWatery stools from 35 g in a single dose
Sorbitol, mannitolLow in IBS10 g is enough to trigger symptoms
Maltitol, isomalt, lactitolLowLaxative effect at moderate doses

If you have irritable bowel syndrome, polyols count among the FODMAPs. During the reduction phase, Monash University sets the threshold at 0.4 g of polyols per serving:

  • Swap sorbitol, mannitol, xylitol, maltitol, isomalt and lactitol for other options.
  • Erythritol, mostly absorbed, often goes down well: test it during reintroduction.
  • Intense sweeteners (aspartame, sucralose, stevia, acesulfame K) are not FODMAPs. Still check the label of table sweeteners: many contain polyols or inulin.

Our complete FODMAP guide walks you through it step by step.


12. Appetite and Sweet Taste

You often hear that sweeteners "keep sugar cravings going" or "trick the brain". The trials do not confirm this:

  • Sweeteners increase neither appetite nor the amount eaten at the next meal.
  • In the SWEET trial, a sweetened drink even reduced the desire for sweet foods compared with water.
  • The Sweet Tooth trial (2025) assigned 180 Dutch adults to a low, medium or high sweetness eating pattern for six months. Result: no difference in liking for sweetness.

So removing sweet taste does not "retrain" your liking for sweetness. This finding matches our approach: we do not ask you to give up the pleasure of sweet foods, but to build an eating pattern that keeps you full. Find out how in Eat what you love.


13. Pregnancy, Children and Special Situations

13.1 Pregnancy

Canadian and Danish cohorts link daily diet drink consumption during pregnancy to more overweight in the child. These studies remain observational, and no randomised trial exists. Sweeteners cross the placenta, but no health authority recommends keeping them below the ADI. Our advice: water first, occasional use without worry.

13.2 Breastfeeding

Acesulfame K passes into breast milk and appears in the blood of every infant studied. Sucralose passes far less. The consequences remain unknown. While breastfeeding, choose water and unsweetened drinks.

13.3 Children

Water and milk remain the reference drinks. If the choice comes down to a sugary drink or a diet drink, the diet version limits weight gain. The American Heart Association recommends against prolonged use in children, except in diabetes.

13.4 Other Situations

  • Phenylketonuria: aspartame is contraindicated.
  • Migraine: a double-blind trial showed that some people sensitive to aspartame had more headaches. A personal elimination test remains reasonable.
  • Kidney failure: the kidneys clear erythritol, and it accumulates when kidney function declines. Keep amounts modest.
  • After bariatric surgery: polyols can worsen diarrhoea and dumping symptoms.
  • Dental health: the European Union recognises that chewing sugar-free gum for at least 20 minutes after meals helps protect tooth enamel.
  • Pets: xylitol is highly toxic to dogs. Keep your chewing gum out of their reach.

14. In the Kitchen: Which Sweetener for Which Use?

Use Good choices Why
Cakes, oven baking Acesulfame K, erythritol They withstand heat. Sucralose can form chlorinated compounds above 120 °C, and stevia can lose part of its sweetening power.
Cold desserts, yoghurts, drinks All No temperature constraint.
Hot sweet dishes Add aspartame after cooking Aspartame breaks down with heat: about 50 % disappears after 20 minutes at 180 °C.
Texture and volume A small amount of polyol Intense sweeteners provide neither volume nor browning. Keep an eye on your digestive tolerance.

15. Our Personalised Approach at Diaeta

We give you no forbidden foods and no blacklist. We start from your real habits to build a strategy that suits you:

  • Do you drink sugary sodas? The diet version is a real step forward. We then work towards water, still, sparkling or flavoured at home, at your own pace.
  • Do you already drink diet versions? Nothing urgent. Other levers weigh far more on your health.
  • Do you have diabetes? We build sweeteners into your plan and teach you to spot hidden polyols.
  • Do you have a sensitive gut? We identify the polyols that trigger your symptoms and the ones you tolerate.
  • Do you have a history of cardiovascular disease? We choose the best-suited options together.

Our goal stays the same: an eating pattern without hunger, made of foods you find tasty, and results that last.

Do you have questions about sweeteners, your blood sugar or your weight? Book an appointment for a personalised consultation in Brussels. Together, we will build your tailored nutrition plan.


Scientific References

  • World Health Organization. Use of non-sugar sweeteners: WHO guideline. Geneva: WHO; 2023.
  • Rios-Leyvraz M, Montez J. Health effects of the use of non-sugar sweeteners: a systematic review and meta-analysis. Geneva: WHO; 2022.
  • Riboli E, et al. Carcinogenicity of aspartame, methyleugenol, and isoeugenol. Lancet Oncol. 2023;24(8):848-850.
  • EFSA FAF Panel. Re-evaluation of saccharin and its salts (E 954). EFSA J. 2024;22(11):e9044.
  • EFSA FAF Panel. Re-evaluation of acesulfame K (E 950). EFSA J. 2025;23(4):e9317.
  • EFSA FAF Panel. Re-evaluation of neotame (E 961). EFSA J. 2025;23(7):e9480.
  • EFSA FAF Panel. Re-evaluation of sucralose (E 955). EFSA J. 2026;24(2):e9854.
  • EFSA FAF Panel. Re-evaluation of erythritol (E 968). EFSA J. 2023;21(12):e8430.
  • EFSA FAF Panel. Steviol glycosides (E 960a-d): modification of the ADI. EFSA J. 2024;22(11):e9045.
  • BfR. Sucralose: heating above 120 °C can produce substances that are harmful to health. Opinion 012/2019.
  • Huvaere K, et al. Dietary intake of artificial sweeteners by the Belgian population. Food Addit Contam A. 2012;29:54-65.
  • Rogers PJ, Appleton KM. The effects of low-calorie sweeteners on energy intake and body weight. Int J Obes. 2021;45:464-478.
  • McGlynn ND, et al. Low- and no-calorie sweetened beverages as a replacement for sugar-sweetened beverages. JAMA Netw Open. 2022;5:e222092.
  • Pang MD, et al. Sweeteners and sweetness enhancers on weight management and gut microbiota: the SWEET study. Nat Metab. 2025;7:2083-2098.
  • de Ruyter JC, et al. A trial of sugar-free or sugar-sweetened beverages and body weight in children. N Engl J Med. 2012;367:1397-1406.
  • Zhang X, et al. Non-nutritive sweetened beverages and postprandial glycemic and endocrine responses. Nutrients. 2023;15:1050.
  • Suez J, et al. Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance. Cell. 2022;185:3307-3328.
  • Debras C, et al. Artificial sweeteners and risk of type 2 diabetes. Diabetes Care. 2023;46:1681.
  • Debras C, et al. Artificial sweeteners and risk of cardiovascular diseases. BMJ. 2022;378:e071204.
  • Debras C, et al. Artificial sweeteners and cancer risk. PLoS Med. 2022;19:e1003950.
  • Witkowski M, et al. The artificial sweetener erythritol and cardiovascular event risk. Nat Med. 2023;29:710-718.
  • Witkowski M, et al. Ingestion of erythritol, but not glucose, enhances platelet reactivity. Arterioscler Thromb Vasc Biol. 2024;44:2136-2141.
  • Witkowski M, et al. Xylitol is prothrombotic and associated with cardiovascular risk. Eur Heart J. 2024;45:2439-2452.
  • Zhao L, et al. Sugar- and artificially sweetened beverages and liver cancer. JAMA. 2023;330:537.
  • Morder KM, et al. Sucralose consumption ablates cancer immunotherapy response through microbiome disruption. Cancer Discov. 2025;15:2278-2297.
  • Ayoub-Charette S, et al. Reconciling conflicting evidence on low- and no-calorie sweeteners: umbrella review. Appl Physiol Nutr Metab. 2025;50:1-26.
  • Wulandari DT, et al. Sucralose and gut microbiota: meta-analysis of RCTs. Int J Mol Sci. 2026;27:8377.
  • Storey D, et al. Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid. Eur J Clin Nutr. 2007;61:349-354.
  • Yao CK, et al. Dietary sorbitol and mannitol: absorption in healthy individuals and IBS. J Hum Nutr Diet. 2014;27(Suppl 2):263-275.
  • Varney J, et al. FODMAPs: food composition, defining cutoff values and international application. J Gastroenterol Hepatol. 2017;32(Suppl 1):53-61.
  • Čad EM, et al. The Sweet Tooth Trial. Am J Clin Nutr. 2025;123:101073.
  • Sylvetsky AC, et al. Transmission of sucralose and acesulfame-potassium via human milk. Am J Clin Nutr. 2024;120:846-853.
  • Azad MB, et al. Artificially sweetened beverages during pregnancy and infant BMI. JAMA Pediatr. 2016;170:662-670.
  • American Diabetes Association. Standards of Care in Diabetes 2026, Section 5. Diabetes Care. 2026;49(Suppl 1):S89-S131.
  • Reynolds AN, et al. Evidence-based European recommendations for the dietary management of diabetes. Diabetologia. 2023;66:965-985.
  • Johnson RK, et al. Low-calorie sweetened beverages and cardiometabolic health: AHA science advisory. Circulation. 2018;138:e126-e140.

Tags

#sweeteners#aspartame#sucralose#stevia#erythritol#xylitol#polyols#EFSA#WHO#blood sugar#microbiota#FODMAP
ShareShare this article with your network

Related Articles

Magnesium: Complete & Practical Guide to Forms, Food Sources and Supplementation
Expert guide to magnesium supplementation forms: bisglycinate, L-threonate, taurate and citrate - Diaeta Brussels infographic
General Nutrition
Mar 22, 202645 min

Magnesium: Complete & Practical Guide to Forms, Food Sources and Supplementation

Everything you need to know about magnesium: why around half the Western population has inadequate intake, how to identify it, which foods contain the most, and how to choose the right supplementation form for your needs.

Pierre Abou-Zeid
Read article →
Fatty Liver (MASLD): The Way of Eating That Reverses It
Illustration of a stylised liver surrounded by olive oil, oily fish, pulses, nuts and colourful vegetables on a turquoise and green background
Weight Management
Oct 6, 202622 min

Fatty Liver (MASLD): The Way of Eating That Reverses It

Almost one adult in three has excess fat in the liver, often without knowing it. The good news: this condition can be reversed. Find out which weight loss, which plate and which physical activity make fatty liver recede, and what the new medicines change in 2026.

Pierre Abou-Zeid
Read article →
Stopping Ozempic, Wegovy or Mounjaro Without Regaining Weight: What the Science Says
Injection pen next to a colourful plate rich in protein, vegetables and pulses, on a turquoise and green background, illustrating the maintenance phase after GLP-1 treatment
Weight Management
Oct 6, 202622 min

Stopping Ozempic, Wegovy or Mounjaro Without Regaining Weight: What the Science Says

One year after stopping semaglutide, STEP 1 participants had regained about two thirds of the weight they had lost. That figure is not inevitable. Find out what the studies say about stopping, dose reduction and maintenance, and how to prepare this step with your doctor and your dietitian.

Pierre Abou-Zeid
Read article →
Irritable Bowel Syndrome: Rome V Criteria and Treatment in 2026
Scientific illustration of irritable bowel syndrome and the gut-brain axis according to Rome V 2026 criteria
IBS & FODMAP
Jun 3, 202638 min

Irritable Bowel Syndrome: Rome V Criteria and Treatment in 2026

The Rome V consensus, published in early 2026, redefines irritable bowel syndrome. Discover what changes in diagnosis, what research reveals about its autoimmune mechanisms, and how current treatments combined with personalised nutrition restore your digestive comfort.

Pierre Abou-Zeid
Read article →
The SIMO, SIBO and IMO Spectrum: Pathophysiology, Diagnosis and Treatment
Scientific illustration of the SIMO spectrum showing bacteria, methanogenic archaea and yeasts in the small intestine
Gut Health
Jun 3, 202642 min

The SIMO, SIBO and IMO Spectrum: Pathophysiology, Diagnosis and Treatment

Microbial imbalance in the small intestine is not limited to bacteria. Discover the SIMO spectrum, its four forms (SIBO, IMO, hydrogen sulphide, SIFO), how each is diagnosed and treated, and how phased personalised nutrition restores your digestive comfort without deprivation.

Pierre Abou-Zeid
Read article →
Comprehensive Analysis of Oxalate Metabolism, Intestinal Transport Mechanisms, and Dietary Therapeutics
Scientific illustration of oxalate metabolism pathways showing intestinal transport and crystallization in the kidney
Gut Health
Apr 6, 202645 min

Comprehensive Analysis of Oxalate Metabolism, Intestinal Transport Mechanisms, and Dietary Therapeutics

Oxalate cannot be degraded by human cells — its systemic control depends entirely on renal and intestinal excretion. This advanced review covers hepatic synthesis pathways, SLC26A6/SLC26A3 transport kinetics, tight-junction permeability, microbiome-mediated degradation, and a complete clinical food database for dietary therapeutic guidance.

Pierre Abou-Zeid
Read article →
Sans Faim Approved

Ready to Transform Your Diet?

Book a personalized consultation with an NIHDI Registered

Book Appointment